R. Adam, Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR), Journal of Hepatology, vol.57, issue.3, pp.675-688, 2012.
DOI : 10.1016/j.jhep.2012.04.015

C. Duvoux, B. Malassagne, J. M. Métreau, C. Hézode, and D. Cherqui, Synopsis: liver transplantation in adults: indications, results and postoperative follow

C. Duvoux and D. Samuel, La transplantation h??patique, Gastroent??rologie Clinique et Biologique, vol.33, issue.8-9, pp.868-881, 2009.
DOI : 10.1016/j.gcb.2009.05.003

K. D. Watt, R. A. Pedersen, W. K. Kremers, J. K. Heimbach, and M. R. Charlton, Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-Up Study, American Journal of Transplantation, vol.137, issue.6
DOI : 10.1111/j.1600-6143.2007.02082.x

P. Burra and K. I. Rodriguez-castro, neoplasms, World Journal of Gastroenterology, vol.21, issue.29, pp.8753-8768, 2015.
DOI : 10.1097/01.SLA.0000033429.89424.F8

C. Jiménez-romero, tumors in liver transplant recipients focusing on alcoholic cirrhosis, World Journal of Hepatology, vol.7, issue.7, pp.942-953, 2015.
DOI : 10.4254/wjh.v7.i7.942

K. D. Watt, Long-term Probability of and Mortality From De Novo Malignancy After Liver Transplantation, Gastroenterology, vol.137, issue.6, pp.2010-2017, 2009.
DOI : 10.1053/j.gastro.2009.08.070

A. Gutierrez-dalmau and J. M. Campistol, Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients, Drugs, vol.120, issue.6, pp.1167-1198, 2007.
DOI : 10.3748/wjg.v11.i10.1420

O. Donovan and P. , Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage, Science, vol.309, issue.5742, pp.1871-1874, 2005.
DOI : 10.1126/science.1114233

M. Maluccio, Tacrolimus enhances transforming growth factor-??1 expression and promotes tumor progression, Transplantation, vol.76, issue.3, pp.597-602, 2003.
DOI : 10.1097/01.TP.0000081399.75231.3B

M. Hojo, Cyclosporine induces cancer progression by a cell-autonomous mechanism, Nature, vol.157, issue.6719, pp.530-534, 1999.
DOI : 10.1016/S0022-5347(01)64787-6

M. Suthanthiran, M. Hojo, M. Maluccio, D. J. Boffa, and F. L. Luan, Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy, Trans. Am

A. S. Tjon, Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: An association with C2 monitoring and recipient age, Liver Transplantation, vol.6, issue.7, pp.837-846, 2010.
DOI : 10.1038/clpt.1993.132

F. Van-der-heide, G. Dijkstra, R. J. Porte, J. H. Kleibeuker, and E. B. Haagsma, Smoking behavior in liver transplant recipients, Liver Transplantation, vol.13, issue.6, pp.648-655, 2009.
DOI : 10.1016/S0033-3182(93)71887-3

J. I. Herrero, Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal, Liver Transplantation, vol.28, issue.suppl 2
DOI : 10.1002/hep.510280306

R. Pfitzmann, Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease, Liver Transplantation, vol.36, issue.2, pp.197-205, 2007.
DOI : 10.1002/lt.20934

A. Jain, LONG-TERM FOLLOW-UP AFTER LIVER TRANSPLANTATION FOR ALCOHOLIC LIVER DISEASE UNDER TACROLIMUS1, Transplantation, vol.70, issue.9, pp.1335-1342, 2000.
DOI : 10.1097/00007890-200011150-00012

C. Jiménez, Upper aerodigestive tract and lung tumors after liver transplantation, Transplantation Proceedings, vol.35, issue.5, pp.1900-1901, 2003.
DOI : 10.1016/S0041-1345(03)00641-9

C. Duvoux, INCREASED INCIDENCE OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS AFTER LIVER TRANSPLANTATION FOR ALCOHOLIC CIRRHOSIS, Transplantation, vol.67, issue.3, pp.418-421, 1999.
DOI : 10.1097/00007890-199902150-00014

J. Dumortier, Negative Impact of De Novo Malignancies Rather than Alcohol Relapse on Survival After Liver Transplantation for Alcoholic Cirrhosis: A Retrospective Analysis of 305 Patients in a Single Center, The American Journal of Gastroenterology, vol.45, issue.5, pp.1032-1041, 2007.
DOI : 10.1097/00007890-200011150-00012

S. Kenngott, A. L. Gerbes, R. Schauer, and M. Bilzer, Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis, Transplant International, vol.80, issue.9
DOI : 10.1016/S0002-9270(99)00039-8

A. Finkenstedt, Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients, Am. J. Transplant. Off. J

N. Chandok and K. D. Watt, Burden of de novo malignancy in the liver transplant recipient, Liver Transplantation, vol.92, issue.suppl
DOI : 10.1097/TP.0b013e31823104ec

J. Herrero, De novo malignancies following liver transplantation: Impact and recommendations, Liver Transplantation, vol.32, issue.S2, pp.90-94, 2009.
DOI : 10.7326/0003-4819-150-3-200902030-00010

URL : http://onlinelibrary.wiley.com/doi/10.1002/lt.21898/pdf

H. Schrem, Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection, Liver Transplantation, vol.19, issue.suppl 5
DOI : 10.1002/lt.23566

S. Sellami, Pronostic et contr??le locor??gional des cancer ORL localement ??volu??s de stade N3(>6cm), Cancer/Radioth??rapie, vol.20, issue.6-7, pp.714-715, 2016.
DOI : 10.1016/j.canrad.2016.08.006

S. J. Presser, De novo esophageal neoplasia after liver transplantation, Liver Transplantation, vol.27, issue.3, pp.443-450, 2007.
DOI : 10.3748/wjg.v11.i10.1420

E. Thimonier, malignancies after liver transplantation for alcoholic liver disease, Clinical Transplantation, vol.16, issue.Suppl 1, pp.1339-1348, 2014.
DOI : 10.1111/j.1432-2277.2003.tb00287.x